To ensure the accuracy of our patient satisfaction scores, we require that providers who see patients receive
a minimum number of completed patient-submitted surveys before their reviews are listed on their profiles.
Star ratings on this site are collected on a rolling basis from the previous 12 months.
Additionally, some of the physicians listed on our site do not see patients directly, and therefore, do not receive
evaluation and ratings from patients.
Where you start your cancer care matters!
I am honored to be part of the surgical oncology team providing care for patients with skin cancer (including melanoma, merkel cell carcinoma, advance squamous cell carcinoma), sarcomas, and gastrointestinal cancers. I treasure my relationship with my patients and thrive to provide the very best care for patients who undergo surgery and throughout the rest of their cancer journey. I follow early stage melanoma patients as well as melanoma survivors in the survivor clinic.
MS,Physician Assistant Studies, Indiana University, Indianapolis, IN, 2015
PhD, Pharmacology, Indiana University School of Medicine, Indianapolis, IN, 2008
BS, Biochemistry, Nanjing University, China, 1998
National Commission on Certification of Physician Assistants- Certified, 2015-Present
Physician Assistant - Certified, Pennsylvania State License
Physician Assistant Certified
Member, American Society of Clinical Oncology
Society of Surgical Oncology (SSO)
Association of Physician Assistants in Oncology (APAO)
Moslim, M., Li, H., Lefton, M., Ruth, K., Nagarathinam, R.,Cooper, H., Reddy, S. Survival and Recurrence in Pancreatobiliary Versus Intestinal Histology of Ampullary Carcinoma. Journal of clinical oncology and research, August 2001. DOI: 10.31487/j.COR.2021.08.09
Renzetti M , Solimon I , Loo K , Lamb E , Wu H , Luo B, Liu H, Olszanski A, Movva S, Lango M , Reddy S, Farma JM. Molecular Profiling in Patients with Nodular versus Superficial Spreading Melanoma. Annual Academic Surgical Congress Abstract ID ACS20180209. Jacksonville, FL, Feb 2018
Renzetti M, Soliman I, Wu H, Luo B, Liu H, Olszansi A, Movva S, Lango M, Reddy S. Zih F. Farma JM. Evaluation of Molecular Profile in High Risk Class 2 MelanomaDx Melanoma Patients. Annual Academic Surgical Congress-Quick Shot Presentation. Las Vegas, NV; February 2017
Fan, Q., Gu, D., Liu, H. et al and Xie, J. Defective TGF-β in bone marrow-derived cell prevents Hedgehog-induced skin tumors. Cancer Res. 74(2): 471-83, 2014
Gu D., Liu H., Su G., et al and Xie J. Combining Hedgehog signaling inhibition with focal irradiation on reduction of pancreatic cancer metastasis. Mol Cancer Ther. 12(6): 1038-48, 2013
Liu H., Wu, X. Dong, Z., et al and Zhang, J. T. Fatty acid synthase causes drug resistance by inhibiting TNF-α and ceramide production. J Lipid Res, 54 (3): 776-85, 2013
Liu, H., Liu, J., Wu, X and Zhang, J.T. Biochemistry, molecular biology, and pharmacology of fatty acid synthase, an emerging therapeutic target and diagnosis/prognosis marker. Int J Biochem Mol Bio. 1(1): 69–89, 2010
Yang, Y., Liu, H., et al and Zhang, J.T. Role of fatty acid synthase in gemcitabine and radiation resistance of pancreatic cancers. Int J Biochem Mol Biol. 2(1): 89–98, 2011
Liu, H., Liu, Y. and Zhang, J.T. A new mechanism of drug resistance in breast cancer cells: fatty acid synthase overexpression-mediated palmitate overproduction. Mol Cancer Ther. 7(2):263-70,2008
Liu, Y.; Liu, H.; Han, B.; Zhang, J.T. Identification of 14-3-3- as a contributor to drug resistance in human breast cancer cells using functional proteomics analysis. Cancer Res.66(6):3248-3255,2006
The following ratings and reviews are based on verified feedback collected from independently administered
patient experience surveys. The ratings and comments submitted by patients reflect their own views and opinions.
Patient identities are withheld to ensure confidentiality and privacy.
Learn more about our Patient Experience Ratings.